Mats Jerkeman

Professor, specialistläkare, Adjungerad Professor, Överläkare
Fler filtreringsmöjligheter
  1. 2019
  2. Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

    Biccler, J. L., Glimelius, I., Eloranta, S., Smeland, K. B., Brown, P. D. N., Jakobsen, L. H., Frederiksen, H., Mats Jerkeman, Fosså, A., Andersson, T. M. L., Holte, H., Bøgsted, M., El-Galaly, T. C. & Smedby, K. E., 2019 mar 20, I : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 9, s. 703-713 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

    Fredrik Ellin, Maurer, M. J., Srour, L., Farooq, U., Mats Jerkeman, Connors, J. M., Smedby, K. E., Bennani, N. N., Ansell, S. M., Slack, G. W., Cerhan, J. R., Relander, T., Feldman, A. L. & Savage, K. J., 2019, I : British Journal of Haematology.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  4. Inflammatory potential of diet and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition

    Solans, M., Benavente, Y., Saez, M., Agudo, A., Jakszyn, P., Naudin, S., Hosnijeh, F. S., Gunter, M., Huybrechts, I., Ferrari, P., Besson, C., Mahamat-Saleh, Y., Boutron-Ruault, M. C., Kühn, T., Kaaks, R., Boeing, H., Lasheras, C., Sánchez, M. J., Amiano, P., Chirlaque, M. D. & 26 andraArdanaz, E., Schmidt, J. A., Vineis, P., Riboli, E., Trichopoulou, A., Karakatsani, A., Valanou, E., Masala, G., Agnoli, C., Tumino, R., Sacerdote, C., Mattiello, A., Skeie, G., Weiderpass, E., Mats Jerkeman, Joana Alves Dias, Späth, F., Nilsson, L. M., Dahm, C. C., Overvad, K., Petersen, K. E. N., Tjønneland, A., de Sanjose, S., Vermeulen, R., Nieters, A. & Casabonne, D., 2019, I : European Journal of Nutrition.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition

    Costas, L., Lujan-Barroso, L., Benavente, Y., Allen, N. E., Amiano, P., Ardanaz, E., Besson, C., Boeing, H., Bueno-de-Mesquita, B., Cervenka, I., Fortner, R. T., Fournier, A., Gunter, M., Harlid, S., Huerta, J. M., Jerkeman, M., Jirström, K., Kaaks, R., Karakatsani, A., Khaw, K. T. & 22 andraKotanidou, A., Lund, E., Masala, G., Mattiello, A., Melin, B., Menéndez, V., Murphy, N., Nieters, A., Overvad, K., Riboli, E., Sacerdote, C., Sánchez, M. J., Schmidt, J. A., Sieri, S., Tjønneland, A., Trichopoulou, A., Tumino, R., Vermeulen, R., Weiderpass, E., de Sanjosé, S., Agudo, A. & Casabonne, D., 2019, I : American Journal of Epidemiology. 188, 2, s. 274-281 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2018
  7. Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition

    Solans, M., Benavente, Y., Saez, M., Agudo, A., Naudin, S., Hosnijeh, F. S., Noh, H., Freisling, H., Ferrari, P., Besson, C., Mahamat-Saleh, Y., Boutron-Ruault, M. C., Kühn, T., Kaaks, R., Boeing, H., Lasheras, C., Rodríguez-Barranco, M., Amiano, P., Huerta, J. M., Barricarte, A. & 26 andraSchmidt, J. A., Vineis, P., Riboli, E., Trichopoulou, A., Bamia, C., Peppa, E., Masala, G., Agnoli, C., Tumino, R., Sacerdote, C., Panico, S., Skeie, G., Weiderpass, E., Mats Jerkeman, Ulrika Ericson, Späth, F., Nilsson, L. M., Dahm, C. C., Overvad, K., Bolvig, A. K., Tjønneland, A., de Sanjose, S., Buckland, G., Vermeulen, R., Nieters, A. & Casabonne, D., 2018 dec 26, I : International Journal of Cancer.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

    A. Ljungars, Mårtensson, L., Jenny Mattsson, Kovacek, M., Sundberg, A., Tornberg, U-C., B. Jansson, Persson, N., V. Kuci Emruli, S. Ek, M. Jerkeman, M. Hansson, G. Juliusson, M. Ohlin, Frendéus, B., Teige, I. & Mattsson, M., 2018 dec 1, I : JCO Precision Oncology. 2, 1

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study

    T. Wästerlid, Mohammadi, M., Smedby, K. E., Glimelius, I., M. Jerkeman, Bottai, M. & Eloranta, S., 2018 okt 28, I : Journal of Internal Medicine.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of followup

    Hagström, H., Andreasson, A., Carlsson, A. C., Mats Jerkeman & Carlsten, M., 2018 aug 23, I : PLoS ONE. 13, 8, e0202651.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

    Ekberg, S., Mats Jerkeman, Andersson, P. O., Enblad, G., Wahlin, B. E., Hasselblom, S., Andersson, T. M., Eloranta, S. & Smedby, K. E., 2018 aug 1, I : American Journal of Hematology. 93, 8, s. 1020-1028 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    Rule, S., Jurczak, W., M. Jerkeman, Rusconi, C., Trneny, M., Offner, F., Caballero, D., Joao, C., Witzens-Harig, M., Hess, G., Bence-Bruckler, I., Cho, S. G., Thieblemont, C., Zhou, W., Henninger, T., Goldberg, J., Vermeulen, J. & Dreyling, M., 2018 aug, I : Leukemia. 32, 8, s. 1799-1803

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

    Freiburghaus, C., Venera Kuci Emruli, Johansson, A., Eskelund, C. W., Grønbæk, K., Roger Olsson, Fredrik Ek, Mats Jerkeman & Sara Ek, 2018 apr 25, I : BMC Cancer. 18, 1, 466.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre, open-label, single-arm, phase 2 trial

    Mats Jerkeman, Eskelund, C. W., Hutchings, M., Räty, R., Wader, K. F., Laurell, A., Toldbod, H., Pedersen, L. B., Niemann, C. U., Dahl, C., Kuitunen, H., Geisler, C. H., Grønbæk, K. & Kolstad, A., 2018 mar, I : The Lancet Haematology. 5, 3, s. e109-e116

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: A critical assessment of the R-IPI, IPI, and NCCN-IPI

    Biccler, J., Eloranta, S., de Nully Brown, P., Frederiksen, H., Mats Jerkeman, Smedby, K. E., Bøgsted, M. & El-Galaly, T. C., 2018 jan, I : Cancer Medicine. 7, 1, s. 114-122

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study

    Fredrik Ellin, Mats Jerkeman, Törnqvist, J., Brudin, L. & Relander, T., 2018, I : Hematological Oncology. 36, 1, s. 159-165

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma

    Eskelund, C. W., Alexandra Albertsson-Lindblad, Kolstad, A., Laurell, A., Räty, R., Pedersen, L. B., Geisler, C. H., Mats Jerkeman & Grønbæk, K., 2018, I : Haematologica. 103, 11, s. e541-e543

    Forskningsoutput: TidskriftsbidragLetter

  18. Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

    Dang, N. H., Ogura, M., Castaigne, S., Fayad, L. E., Mats Jerkeman, Radford, J., Pezzutto, A., Bondarenko, I. N., Stewart, D. A., Shnaidman, M., Sullivan, S., Vandendries, E., Tobinai, K., Ramchandren, R., Hamlin, P. A., Giné, E. & Ando, K., 2018, I : British Journal of Haematology. 182, 4, s. 583-586

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  19. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations

    Dreyling, M., Aurer, I., Cortelazzo, S., Hermine, O., Hess, G., Mats Jerkeman, Le Gouill, S., Ribrag, V., Trněný, M., Visco, C., Walewski, J., Zaja, F. & Zinzani, P. L., 2018, I : Leukemia and Lymphoma. 59, 8, s. 1814-1828

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2017
  21. International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

    Maurer, M. J., Fredrik Ellin, Srour, L., Mats Jerkeman, Bennani, N. N., Connors, J. M., Slack, G. W., Smedby, K. E., Ansell, S. M., Link, B. K., Cerhan, J. R., Relander, T., Savage, K. J. & Feldman, A. L., 2017 dec 20, I : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 36, s. 4019-4026 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study

    Henrik Cederleuf, Hjort Jakobsen, L., Fredrik Ellin, de Nully Brown, P., Stauffer Larsen, T., Bøgsted, M., Relander, T., Mats Jerkeman & El-Galaly, T. C., 2017 dec 2, I : Leukemia and Lymphoma. 58, 12, s. 2815-2823 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.

    Karvonen, H., Chiron, D., Niininen, W., Sara Ek, Mats Jerkeman, Moradi, E., Nykter, M., Heckman, C. A., Kallioniemi, O., Murumägi, A. & Ungureanu, D., 2017 nov 9, I : Blood Advances. 1, 24, s. 2257-2268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

    Eskelund, C. W., Dahl, C., Hansen, J. W., Westman, M., Kolstad, A., Pedersen, L. B., Montano-Almendras, C. P., Husby, S., Freiburghaus, C., Sara Ek, Pedersen, A., Niemann, C., Raty, R., Brown, P., Geisler, C. H., Andersen, M. K., Guldberg, P., Mats Jerkeman & Grønbæk, K., 2017 okt 26, I : Blood. 130, 17, s. 1903-1910 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma

    Tove Wästerlid, Nordström, L., Freiburghaus, C., Pedersen, M., Nørgaard, P., Gang, A. O., Brown, P., Michael Dictor, Mats Jerkeman & Sara Ek, 2017, I : Leukemia & Lymphoma. 58, 7, s. 1760-1763 4 s.

    Forskningsoutput: TidskriftsbidragLetter

  26. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

    Hess, G., Rule, S., Jurczak, W., Mats Jerkeman, Santucci Silva, R., Rusconi, C., Caballero, D., Joao, C., Witzens-Harig, M., Bence-Bruckler, I., Cho, S-G., Zhou, W., Goldberg, J. D., Trambitas, C., Enny, C., Vermeulen, J., Traina, S., Chiou, C. F., Diels, J. & Dreyling, M., 2017, I : Leukemia and Lymphoma. 58, 12, s. 2824-2832

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

    Kolstad, A., Pedersen, L. B., Eskelund, C. W., Husby, S., Grønbæk, K., Jerkeman, M., Laurell, A., Räty, R., Elonen, E., Andersen, N. S., Brown, P. D. N., Kimby, E., Bentzen, H., Sundström, C., Ehinger, M., Karjalainen-Lindsberg, M-L., Delabie, J., Ralfkiær, E., Fagerli, U-M., Nilsson-Ehle, H. & 4 andraLauritzsen, G. F., Kuittinen, O., Niemann, C. & Geisler, C. H., 2017, I : Biology of Blood and Marrow Transplantation. 23, 3, s. 428-435

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Dreyling, M., Campo, E., Hermine, O., M. Jerkeman, Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., Ladetto, M. & on behalf of the ESMO Guidelines Committee, 2017, I : Annals of Oncology. 28, s. iv62-iv71

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Targeting of B-cell receptor signalling in B-cell malignancies

    M. Jerkeman, Hallek, M., Dreyling, M., Thieblemont, C., Kimby, E. & Staudt, L., 2017, I : Journal of Internal Medicine. 282, 5, s. 415-428

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  30. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study

    Henrik Cederleuf, Bjerregård Pedersen, M., Mats Jerkeman, Relander, T., d'Amore, F. & Fredrik Ellin, 2017, I : British Journal of Haematology. 178, 5, s. 739-746

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2016
  32. Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

    Pauly, F., Fjordén, K., Leppä, S., Holte, H., Björkholm, M., Fluge, Møller Pedersen, L., M. Eriksson, A. Isinger-Ekstrand, C. A.K. Borrebaeck, M. Jerkeman & C. Wingren, 2016 nov 18, I : Blood Cancer Journal. 6, 11, s. e501

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

    Melén, C. M., Enblad, G., Sonnevi, K., Junlén, H. R., Smedby, K. E., Mats Jerkeman & Wahlin, B. E., 2016 nov 1, I : British Journal of Haematology. 175, 4, s. 614-622 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration

    Cheah, C. Y., Bröckelmann, P. J., Chihara, D., Moskowitz, A. J., Engert, A., Mats Jerkeman, El-Galaly, T. C., Augustson, B., Vose, J., Bartlett, N. L., Villa, D., Connors, J. M., Feldman, T., Pinnix, C. C., Milgrom, S. A., Dabaja, B., Oki, Y. & Fanale, M. A., 2016 sep 1, I : American Journal of Hematology. 91, 9, s. 894-899 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4

    Alexandra Albertsson-Lindblad, Kolstad, A., Laurell, A., Räty, R., Grønbæk, K., Sundberg, J., Pedersen, L. B., Ralfkiær, E., Karjalainen-Lindsberg, M-L., Sundström, C., Mats Ehinger, Geisler, C. & Mats Jerkeman, 2016 jun 27, I : Blood. 128, 14, s. 1814-1820

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): Prolonged remissions without survival plateau

    Eskelund, C. W., Kolstad, A., Jerkeman, M., Räty, R., Laurell, A., Eloranta, S., Smedby, K. E., Husby, S., Pedersen, L. B., Andersen, N. S., Eriksson, M., Kimby, E., Bentzen, H., Kuittinen, O., Lauritzsen, G. F., Nilsson-Ehle, H., Ralfkiær, E., Ehinger, M., Sundström, C., Delabie, J. & 7 andraKarjalainen-Lindsberg, M. L., Workman, C. T., Garde, C., Elonen, E., Brown, P., Grønbæk, K. & Geisler, C. H., 2016, I : British Journal of Haematology. 175, 3, s. 410-418

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.

    Dreyling, M., Jurczak, W., Jerkeman, M., Silva, R. S., Rusconi, C., Trneny, M., Offner, F., Caballero, D., Joao, C., Witzens-Harig, M., Hess, G., Bence-Bruckler, I., Cho, S-G., Bothos, J., Goldberg, J. D., Enny, C., Traina, S., Balasubramanian, S., Bandyopadhyay, N., Sun, S. & 3 andraVermeulen, J., Rizo, A. & Rule, S., 2016, I : The Lancet. 387, 10020, s. 770-778

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.

    Jakobsen, L. H., Hutchings, M., de Nully Brown, P., Linderoth, J., Mylam, K. J., Molin, D., Johnsen, H. E., Bøgsted, M., Mats Jerkeman & El-Galaly, T. C., 2016, I : British Journal of Haematology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. 2015
  40. Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.

    Roghanian, A., Teige, I., Mårtensson, L., Cox, K. L., Kovacek, M., Ljungars, A., Mattson, J., Sundberg, A., Vaughan, A. T., Shah, V., Smyth, N. R., Sheth, B., Chan, H. T. C., Li, Z-C., Williams, E. L., Manfredi, G., Oldham, R. J., Mockridge, C. I., James, S. A., Dahal, L. N. & 12 andraHussain, K., Björn Nilsson, Verbeek, J. S., Gunnar Juliusson, Markus Hansson, Mats Jerkeman, Johnson, P. W. M., Davies, A., Beers, S. A., Glennie, M. J., Frendéus, B. & Cragg, M. S., 2015, I : Cancer Cell. 27, 4, s. 473-488

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.

    Fredrik Ellin, Landström, J., Mats Jerkeman & Relander, T., 2015, I : Blood. 126, 1, s. 36-41

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Emerging role of SOX11 in mantle cell lymphoma

    Venera Kuci, Nordström, L., Mats Jerkeman & Sara Ek, 2015, I : Blood and Lymphatic Cancer: Targets and Therapy. 5, s. 35-41

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  43. Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009 - trends in cure proportions by clinical characteristics.

    Glimelius, I., Ekberg, S., Mats Jerkeman, Chang, E. T., Björkholm, M., Andersson, T. M. L., Smedby, K. E. & Eloranta, S., 2015, I : American Journal of Hematology. 90, 12, s. 1128-1134

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study

    Hedstrom, G., Peterson, S., Berglund, M., Mats Jerkeman & Enblad, G., 2015, I : Acta Oncologica. 54, 6, s. 924-932

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.

    Husby, S., Ralfkiaer, U., Garde, C., Zandi, R., Ek, S., Kolstad, A., Jerkeman, M., Laurell, A., Räty, R., Pedersen, L. B., Pedersen, A., Ehinger, M., Sundström, C., Karjalainen-Lindsberg, M-L., Delabie, J., Clasen-Linde, E., Brown, P., Cowland, J., Workman, C. T., Geisler, C. H. & 1 andraGrønbæk, K., 2015, I : Blood. 125, 17, s. 2669-2677

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

    El-Galaly, T. C., Jakobsen, L. H., Hutchings, M., de Nully Brown, P., Nilsson-Ehle, H., Erzsébet Szekely, Mylam, K. J., Hjalmar, V., Johnsen, H. E., Bøgsted, M. & Mats Jerkeman, 2015, I : Journal of Clinical Oncology. 33, 34, s. 3993-3998

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment

    Nord, C., Olofsson, S-E., Glimelius, I., Cedermark, G. C., Ekberg, S., Cavallin-Ståhl, E., Neovius, M., Mats Jerkeman & Smedby, K. E., 2015, I : Acta Oncologica. 54, 10, s. 1770-1780

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study

    Glimelius, I., Ekberg, S., Linderoth, J., Mats Jerkeman, Chang, E. T., Neovius, M. & Smedby, K. E., 2015, I : Journal of Cancer Survivorship. 9, 4, s. 599-609

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. The impact of age on survival of diffuse large B-cell lymphoma - a population-based study

    Hedstrom, G., Oskar Hagberg, Mats Jerkeman & Enblad, G., 2015, I : Acta Oncologica. 54, 6, s. 916-923

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Total body irradiation after high-dose cytarabine in mantle cell lymphoma: A comparison of Nordic MCL2, HOVON-45, and European MCLYounger trials.

    Hoster, E., Geisler, C. H., Doorduijn, J., van der Holt, B., Walewski, J., Bloehdorn, J., Ribrag, V., Salles, G., Hallek, M., Pott, C., Szymczyk, M., Kolstad, A., Laurell, A., Räty, R., Jerkeman, M., Van't Veer, M., Kluin-Nelemans, J. C., Klapper, W., Unterhalt, M., Dreyling, M. & 1 andraHermine, O., 2015, I : Leukemia.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa